RxDoctor Payments Data

Callie King

Physician Assistant · Lincoln, NENPI 1568181865

Payments from drug & device makers

$702in general payments, 2019–2025

Across 26 payments — averaging $27.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$173
  • Boston Scientific$123
  • Impulse Dynamics (USA) Inc.$86
  • Novo Nordisk$71
  • Inari Medical, Inc.$39
  • AstraZeneca$31
  • plus $178 from 11 others

What the payments were for

  • Food & beverage$702100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$702 in reported general payments places this provider in the 65th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$30,503
Medicare patients
286
Services billed
488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban122$115,655
JardianceEmpagliflozin82$84,803
EntrestoSacubitril/Valsartan71$71,282
XareltoRivaroxaban79$62,851
Repatha SureclickEvolocumab35$34,707
BrilintaTicagrelor20$10,584
FarxigaDapagliflozin Propanediol12$8,473
Ranolazine ErRanolazine37$3,052
Metoprolol Succinate166$2,548
Rosuvastatin Calcium127$1,774
Potassium Chloride91$1,628
Flecainide Acetate34$1,502
Atorvastatin Calcium192$1,365
Ezetimibe96$1,132
Amlodipine Besylate148$1,070

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$115,655122 claims
NovartisEntresto$13$71,28271 claims
Johnson & JohnsonXarelto$28$62,85179 claims
AstraZenecaBrilinta, Farxiga$31$19,05732 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →